openPR Logo
Press release

Diverticular Disease Market Size, Share & Growth Analysis

11-17-2025 02:02 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Diverticular Disease

Diverticular Disease

The Diverticular Disease Market is expanding rapidly as cases of diverticulosis and diverticulitis increase worldwide. With aging populations, lifestyle shifts, improved diagnostics, and new treatment options, the market is positioned for strong growth through 2034.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51993

Understanding the Diverticular Disease Market
Diverticular disease refers to conditions involving small pouches (diverticula) that form in the colon wall. These include:
• Diverticulosis: Presence of pouches, often without symptoms
• Diverticulitis: Inflammation or infection of the pouches
• Diverticular bleeding
While many patients manage symptoms without complications, severe cases can require hospitalization, antibiotics, or surgery. Factors contributing to rising prevalence include:
• Low-fiber diets
• Sedentary lifestyles
• Obesity
• Aging populations
• Chronic constipation
• Genetic predisposition
Early diagnosis through CT scans, colonoscopy, and ultrasound is improving treatment outcomes and boosting demand for GI care globally.

Key Players Driving the Market
A mix of pharmaceutical companies, medical device manufacturers, and gastrointestinal care providers contribute to this market's steady growth. Major players include:
• Abbott Laboratories
• Pfizer Inc.
• Takeda Pharmaceutical
• Johnson & Johnson
• Novartis AG
• Bayer AG
• Merck & Co., Inc.
• Allergan (AbbVie)
• Medtronic
• Boston Scientific
These companies offer antibiotics, anti-inflammatory medications, nutritional supplements, GI diagnostic systems, and surgical equipment.

Explore Full Report here: https://exactitudeconsultancy.com/reports/51993/diverticular-disease-market

Market Growth and Outlook
The Diverticular Disease Market is expected to grow at a strong CAGR through 2034, driven by:
• A rapidly aging global population
• Rising incidence of digestive and lifestyle-related diseases
• Greater awareness and earlier diagnosis
• Increasing adoption of minimally invasive GI procedures
• Enhanced hospital and endoscopy center infrastructure
• Development of targeted and combination therapies
Demand is increasing particularly in regions with Western-style diets and urban lifestyles.

Key Market Segments and Insights
By Disease Type
• Diverticulosis
• Diverticulitis
• Diverticular Bleeding
Diverticulitis remains the largest segment due to frequent need for medical and surgical intervention.

By Treatment Type
• Medications
o Antibiotics
o Pain relievers
o Anti-inflammatory drugs
o Probiotics
• Dietary & Nutritional Interventions
o High-fiber diets
o Fiber supplements
• Minimally Invasive Procedures
o Endoscopic drainage
o Abscess management
• Surgical Treatment
o Colon resection (for recurrent or severe cases)
Minimally invasive techniques are gaining popularity due to shorter recovery times and fewer complications.

By Diagnosis Method
• CT Scan
• Colonoscopy
• Ultrasound
• MRI
• Blood Tests
CT scans remain the most accurate and widely used method for diagnosing acute diverticulitis.

By End User
• Hospitals
• Gastroenterology Clinics
• Diagnostic Centers
• Ambulatory Surgical Centers
• Homecare Settings
Hospitals hold the largest share due to the need for imaging, IV antibiotics, and emergency care.

Regional Market Overview
North America
The largest market, driven by high prevalence of diverticular disease, advanced diagnostic facilities, and greater awareness.
Europe
Strong presence due to aging populations, well-developed healthcare systems, and adoption of minimally invasive therapies.
Asia-Pacific
Expected to grow at the fastest CAGR, fueled by:
• Rising lifestyle-related GI disorders
• Increasing fiber-poor diets
• Growing hospital infrastructure
• Expanding medical tourism in India and Southeast Asia
Latin America, Middle East & Africa
Steady growth driven by improving diagnosis, increased access to GI specialists, and modernized healthcare systems.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=51993

Key Drivers of Market Growth
1. Aging Population
Diverticular disease is significantly more common in adults over 50, making population aging a major market driver.
2. Lifestyle and Dietary Changes
Low-fiber diets and sedentary habits are increasing global risk levels.
3. Advancements in Imaging and Diagnostics
High-resolution CT scans, improved endoscopy systems, and enhanced ultrasound tools enable faster diagnosis.
4. Growth in Minimally Invasive GI Care
Endoscopic and laparoscopic interventions reduce hospital stays and improve recovery.
5. Rising Awareness of Preventive Care
Fiber-rich diets, probiotics, and early detection efforts are expanding patient engagement.

Key Events in the Last Five Years
• Development of new antibiotics and targeted anti-inflammatory drugs
• Increased research on gut microbiome therapies for diverticular disease
• Growth in endoscopic management techniques for abscess and perforation
• Rising adoption of laparoscopic colon resection
• AI-powered imaging tools improving diagnostic accuracy
• Public health initiatives promoting high-fiber diets
These advances are reshaping treatment standards and improving patient outcomes.

Conclusion
The Diverticular Disease Market is growing steadily as global digestive health concerns increase and healthcare systems invest in better GI diagnostics and therapeutic solutions. With aging populations, lifestyle changes, and advancements in minimally invasive care, the market is entering a more innovative and patient-centered phase.

Companies investing in advanced imaging, microbiome-based treatment solutions, and efficient GI surgical tools will play a major role in shaping the future of diverticular disease management.

This report is also available in the following languages : Japanese (憩室疾患市場), Korean (게실질환 시장), Chinese (憩室病市场), French (Marché des maladies diverticulaires), German (Markt für Divertikulose), and Italian (Mercato delle malattie diverticolari), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/51993/diverticular-disease-market#request-a-sample

Our More Reports:

Neuromodulation Market
https://exactitudeconsultancy.com/reports/60440/global-neuromodulation-market

Magnesium Valproate Market
https://exactitudeconsultancy.com/reports/65927/magnesium-valproate-market

Perampanel Market
https://exactitudeconsultancy.com/reports/66400/perampanel-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diverticular Disease Market Size, Share & Growth Analysis here

News-ID: 4273955 • Views:

More Releases from Exactitude Consultancy

Head and Neck Squamous Cell Carcinomas (HNSCCs) Patient Pool Analysis Market is projected to reach USD 4.68 billion by 2034
Head and Neck Squamous Cell Carcinomas (HNSCCs) Patient Pool Analysis Market is …
The global Head and Neck Squamous Cell Carcinomas (HNSCCs) Patient Pool Analysis Market was valued at USD 2.46 billion in 2024 and is projected to reach USD 4.68 billion by 2034, growing at a CAGR of 6.7% during the forecast period (2025-2034). Rising incidence of oral, oropharyngeal, hypopharyngeal, and laryngeal cancers-driven by tobacco use, alcohol consumption, HPV infection, and environmental carcinogens-is significantly expanding the global HNSCC patient pool. Download Full PDF
Osteoarthritis Patient Pool Analysis Market is projected to reach USD 14.92 billion by 2034
Osteoarthritis Patient Pool Analysis Market is projected to reach USD 14.92 bill …
The global Osteoarthritis (OA) Patient Pool Analysis Market was valued at USD 7.85 billion in 2024 and is projected to reach USD 14.92 billion by 2034, expanding at a CAGR of 6.7% during the forecast period (2025-2034). Osteoarthritis is one of the leading causes of disability worldwide, with a rapidly growing patient population driven by aging demographics, rising obesity rates, increased joint injuries, and expanding diagnostic access across primary and
Soft Tissue Sarcoma (STS) with Lung Metastases Market is projected to reach USD 3.21 billion by 2034
Soft Tissue Sarcoma (STS) with Lung Metastases Market is projected to reach USD …
The global Soft Tissue Sarcoma (STS) with Lung Metastases Market was valued at USD 1.72 billion in 2024 and is projected to reach USD 3.21 billion by 2034, expanding at a CAGR of 6.4% during the forecast period (2025-2034). Rising incidence of advanced sarcomas, limited curative treatment options for metastatic disease, increasing adoption of novel systemic therapies, and advancements in molecular diagnostics are major drivers of market growth. Download Full PDF
Bone Metastasis in Solid Tumors Market is projected to reach USD 29.4 billion by 2034
Bone Metastasis in Solid Tumors Market is projected to reach USD 29.4 billion by …
The global Bone Metastasis in Solid Tumors Market was valued at USD 15.8 billion in 2024 and is projected to reach USD 29.4 billion by 2034, growing at a CAGR of 6.3% during the forecast period (2025-2034). Rising incidence of advanced-stage cancers, longer survival of patients due to improved systemic therapies, increased use of bone-targeting agents, and advancements in diagnostic imaging are the key factors driving market growth. Download Full PDF

All 5 Releases


More Releases for Diverticular

Future Scope of Diverticular Treatment Market Set for Dynamic Development with K …
Coherent Market Insights has released a report titled "Diverticular Treatment Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins. ➤ Get Sample Copy
Global Diverticular Treatment Market Set for Significant Growth as Awareness and …
The global diverticular treatment market is poised for steady expansion over the next decade, fueled by rising incidences of diverticular disease, increasing elderly population, technological advancements in diagnostics, and a growing preference for non-invasive treatments. Industry stakeholders are witnessing a shift in treatment protocols, innovation in pharmaceutical formulations, and expanding healthcare access in emerging economies. Get a free sample report: https://datahorizzonresearch.com/request-sample-pdf/diverticular-treatment-market-4125 Understanding Diverticular Disease and the Market Landscape Diverticular disease, encompassing diverticulosis and
North America Diverticular Treatment Market to Surpass US$ 1.9 Bn by 2031 Amid R …
The North America Diverticular Treatment Market was valued at US$ 986.6 Mn in 2022 and is projected to expand at a CAGR of 7.6% from 2023 to 2031, surpassing US$ 1.9 Bn by the end of 2031. Increasing healthcare awareness, advancements in drug formulations, and improvements in diagnostic technologies are fueling market growth. Diverticular disease, a condition characterized by the formation of small pouches (diverticula) in the walls of the colon,
Diverticular Treatment Market Size 2021 with Key Players Growth Opportunities an …
Latest released, the research study on Global Diverticular Treatment Market Research Report 2021, report comprises growth rate, size, analysis by type, market segment by Application, market competition by manufacturers, share by region, manufacturing cost analysis, Also, the Diverticular Treatment Market offers market breakdown, competitive situation and trends, key raw materials analysis, dynamics, forecast by type, by application and revenue estimates with covid-19 impact till 2027. Get Free sample copy of the
Diverticular Disease Market Expected to Grow 7.5% CAGR with Sucampo Pharmaceutic …
Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber
Diverticular Disease Market 2023 Top Key Players are Sucampo Pharmaceuticals, In …
Market Research Future has added a report titled “Diverticular Disease Market Research Report - Forecast to 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition